ZA971709B - Method of increasing testosterone - Google Patents

Method of increasing testosterone

Info

Publication number
ZA971709B
ZA971709B ZA971709A ZA971709A ZA971709B ZA 971709 B ZA971709 B ZA 971709B ZA 971709 A ZA971709 A ZA 971709A ZA 971709 A ZA971709 A ZA 971709A ZA 971709 B ZA971709 B ZA 971709B
Authority
ZA
South Africa
Prior art keywords
increasing testosterone
testosterone
increasing
Prior art date
Application number
ZA971709A
Other languages
English (en)
Inventor
David B Maclean
David D Thompson
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of ZA971709B publication Critical patent/ZA971709B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
ZA971709A 1996-02-28 1997-02-27 Method of increasing testosterone ZA971709B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2118196P 1996-02-28 1996-02-28

Publications (1)

Publication Number Publication Date
ZA971709B true ZA971709B (en) 1998-08-27

Family

ID=21802799

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA971709A ZA971709B (en) 1996-02-28 1997-02-27 Method of increasing testosterone

Country Status (8)

Country Link
US (1) US6017964A (xx)
EP (1) EP0793961A1 (xx)
JP (1) JPH09315962A (xx)
CN (1) CN1165649A (xx)
AU (1) AU712800B2 (xx)
CA (1) CA2198535C (xx)
IL (1) IL120262A (xx)
ZA (1) ZA971709B (xx)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
CO5271697A1 (es) 2000-01-12 2003-04-30 Pfizer Prod Inc Composiciones y procedimientos para el tratamiento de afecciones que responden a un aumento de testosterona
US20020013327A1 (en) * 2000-04-18 2002-01-31 Lee Andrew G. Compositions and methods for treating female sexual dysfunction
EP1210951B1 (en) * 2000-11-30 2005-02-02 Pfizer Products Inc. Composition containing estrogen agonists/antagonists and testosterone for treating a decline in the level of the hormone testosterone
US20020183532A1 (en) * 2001-06-01 2002-12-05 Roberts William J. Bioavailable prodrugs of androgenic steroids and related method
US7737185B2 (en) * 2001-07-09 2010-06-15 Repros Therapeutics Inc. Methods and compositions with trans-clomiphene
AU2002318225B2 (en) * 2001-07-09 2007-12-13 Repros Therapeutics Inc. Methods and materials for the treatment of testosterone deficiency in men
US20080249183A1 (en) * 2001-11-29 2008-10-09 Steiner Mitchell S Treatment of androgen-deprivation induced osteoporosis
US20040096510A1 (en) * 2001-11-29 2004-05-20 Steiner Mitchell S. Prevention and treatment of androgen-deprivation induced osteoporosis
US20060269611A1 (en) * 2001-11-29 2006-11-30 Steiner Mitchell S Prevention and treatment of androgen-deprivation induced osteoporosis
CA2468719C (en) * 2001-11-29 2011-05-24 Gtx Inc. Prevention and treatment of androgen-deprivation induced osteoporosis
US7524866B2 (en) * 2001-11-29 2009-04-28 Gtx, Inc. Prevention and treatment of androgen—deprivation induced osteoporosis
US20050080143A1 (en) * 2001-11-29 2005-04-14 Steiner Mitchell S. Treatment of androgen-deprivation induced osteoporosis
US20070197664A1 (en) * 2001-11-29 2007-08-23 Steiner Mitchell S Prevention and treatment of androgen-deprivation induced osteoporosis
US6740646B2 (en) 2002-01-16 2004-05-25 Biotest Laboratories, Llc Bioavailable prodrugs of androgenic steroids and related method
US6818668B2 (en) 2002-04-12 2004-11-16 Biotest Laboratories, Llc 5-alkyl-7-alkylcarbonate-isoflavone ester and related method
MX2007000050A (es) * 2004-07-14 2007-07-10 Repros Therapeutics Inc Trans-clomifeno para el tratamiento de hipertrofia de prostata benigna, cancer de prostata, hipogonadismo, trigliceridos elevados y colesterol elevado.
CA2578852A1 (en) * 2004-09-03 2006-03-09 Hormos Medical Corporation Use of a selective estrogen receptor modulator for the manufacture of a pharmaceutical preparation for use in a method for the treatment or prevention of androgen deficiency
US20090215906A1 (en) * 2005-02-04 2009-08-27 Repros Therapeutics Inc. Methods and materials with trans-clomiphene for the treatment of male infertility
NZ560551A (en) * 2005-03-22 2010-02-26 Repros Therapeutics Inc Dosing regimes for trans-clomiphene
NZ591955A (en) 2007-10-16 2011-10-28 Repros Therapeutics Inc Trans-clomiphene for diabetes mellitus type 2
US20090215733A1 (en) * 2008-02-26 2009-08-27 Michael Charles Scally Therapy for the prophylaxis or treatment of adverse body composition changes and/or decreased muscle strength after androgen or gnrh analogue intake
UA113291C2 (xx) 2011-08-04 2017-01-10 Метаболіти транскломіфену і їх застосування
WO2013123218A1 (en) * 2012-02-14 2013-08-22 Repros Therapeutics Inc. Selective estrogen receptor modulators with short half-lives and uses thereof
JP2015535283A (ja) 2012-11-02 2015-12-10 レプロス セラピューティクス インコーポレイティド 癌療法における使用のためのトランス−クロミフェン

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3046719C2 (de) * 1980-12-11 1983-02-17 Klinge Pharma GmbH, 8000 München 1,1,2-Triphenyl-but-1-en-Derivate, Verfahren zu ihrer Herstellung und Arzneimittel
JPH04312526A (ja) * 1991-04-09 1992-11-04 Fujisawa Pharmaceut Co Ltd 骨疾患治療剤
US5389670A (en) * 1993-12-21 1995-02-14 Eli Lilly Company Methods of inhibiting the symptoms of premenstrual syndrome/late luteal phase dysphoric disorder
US5384332A (en) * 1994-05-11 1995-01-24 Eli Lilly And Company Methods for inhibiting aortal smooth muscle cell proliferation and restenosis with 1,1,2-triphenylbut-1-ene derivatives
US5455275A (en) * 1994-05-11 1995-10-03 Eli Lilly And Company Methods for inhibiting endometriosis and uterine fibroid disease with 1,1,2-triphenylbut-1-ene derivatives
US5441986A (en) * 1994-07-19 1995-08-15 Pfizer Inc. Estrogen agonists as remedies for prostate and cardiovascular diseases

Also Published As

Publication number Publication date
CN1165649A (zh) 1997-11-26
CA2198535A1 (en) 1997-08-28
AU712800B2 (en) 1999-11-18
IL120262A0 (en) 1997-06-10
US6017964A (en) 2000-01-25
MX9701532A (es) 1998-06-30
IL120262A (en) 2001-01-28
JPH09315962A (ja) 1997-12-09
CA2198535C (en) 2000-06-20
EP0793961A1 (en) 1997-09-10
AU1496697A (en) 1997-09-04

Similar Documents

Publication Publication Date Title
IL120262A0 (en) Method of increasing testosterone
EP0914115A4 (en) NEUROPROTECTION METHODS
GB9617780D0 (en) Method of treatment
PL332482A1 (en) Intermediate compounds for and method of obtaining olanzaoine
PL318452A1 (en) Method of obtaining peroxyperfluoropolyoxyalkylenes
PL330400A1 (en) Method of obtaining azacyclohexapeptides
PL335074A1 (en) Method of obtaining eprosartane
PL335075A1 (en) Method of obtaining eprosartane
GB9619758D0 (en) Method
PL332077A1 (en) Method of obtaining omepraole
PL313419A1 (en) Method of obtaining beta-naphtole
PL334901A1 (en) Method of obtaining benzothiazolones
GB9605709D0 (en) Method
PL333977A1 (en) Method of obtaining benzisothiazolyn-3-ones
PL339188A1 (en) Method of obtaining oxaphosphorin-2-amines
ZA973988B (en) Method of treatment
GB9618341D0 (en) Method of treatment
PL341358A1 (en) Method of obtaining paroxetin chlorhydride
PL340915A1 (en) Method of obtaining azacycloalkylalkanoyl pseudotetrapeptides
PL317788A1 (en) Method of obtaining 3-isocyanate-propylsilane
PL332075A1 (en) Method of obtaining nizathidine
PL336266A1 (en) Method of obtaining epsilon-caprolactams
PL341302A1 (en) Method of obtaining chlorobenzoxazoles
GB9605482D0 (en) Method
PL332208A1 (en) Method of obtaining benzzothiophenes